Search results
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
WFMJ Youngstown· 11 hours agoPanelists pointed to flawed studies that could have skewed the results, missing follow-up data on...
FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates
Benzinga· 8 hours agoA committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the...
Panelists Named For Retool ‘24 Conference
The Post-Journal· 2 days agoPanel discussions at the Retool’24 Conference on June 11 will feature business experts and developers who work with small and medium manufacturers to...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - The Boston Globe
The Boston Globe· 10 hours agoThe FDA is not required to follow the group’s advice and is expected to make its final decision by...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WUSF 89.7· 8 hours agoA panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for...
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD
New York Times· 13 hours agoAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress...
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 17 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
Faith & Freedom Coalition plans Road to Majority conference
The Washington Times· 13 hours ago“Attendees can expect to hear from an extensive lineup of conservative leaders and expert panelists, with a robust focus on pro-family and pro-freedom policies, empowering ...